Course Description: Ovarian cancer is the fourth leading cause of cancer-related death in women and one of the most frequent gynaecologic malignancies. The median age at diagnosis is 62 years, and the incidence climbs significantly after the age of 60. In many cases, it is completely curable if detected early. The CME-program provides the following basic material about ovary cancer will be covered in these modules: relevant data, risk factors, pertinent anatomy, significant histologic kinds, abstracting, coding, staging, and a general therapeutic strategy. According to available data, Mullerian ducts are the source of ovarian, fallopian tube, and primary peritoneal malignancies, all of which are treated similarly. These modules will therefore attack all three of these cancer locations simultaneously.
Target audience: Oncology/gynaecology-Health-system/ Health-Care Providers
Type of activity: Application
Faculty:
Release date:
Expiration date:
Time to complete activity: Self-pace
Fee:
Objectives of Education
Learners will be able to do the following after completing this activity:
⇒ Analyse the risk and preventative factors for illness development, as well as the epidemiology of ovarian cancer in the United States.
⇒ Examine the pathogenesis of ovarian cancer, as well as its symptoms and subtypes.
⇒ Enumerate the most common adverse effects of ovarian cancer treatment strategies include surgery, chemotherapy, targeted therapy,immunotherapy, and hormonal therapy, as well as patient educationcomponents.
⇒ When suggesting treatment options for individuals with ovarian cancer, use the most recent clinical data.
⇒ Use toxicity management measures when administering therapeutic medicines for the treatment of ovarian cancer.
⇒ Use tactics to overcome impediments to patient access to medicinal agents.